Mercè Jordà
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Sarcoma Diagnosis and Treatment
- Oncology top 2%
Papers in
-
- Renal cell carcinoma treatment 24
- Prostate Cancer Treatment and Research 22
- Prostate Cancer Diagnosis and Treatment 21
- Oncology 50
- Co-authors
- Parvin Ganjei‐AzarMehrdad NadjiAndrew HanlyCarmen Gomez‐FernandezMark S. SolowayOleksandr N. KryvenkoGeorge W. ElgartMurugesan Manoharan
- Journals
- Archives of Pathology & Laboratory Medicine (12 papers)The Journal of Urology (10 papers)Cancer Cytopathology (8 papers)Cancer (7 papers)Applied immunohistochemistry & molecular morphology (7 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mercè Jordà
149 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 117
- Pulmonary and Respiratory Medicine 1.3k
- Oncology 1.0k
- Gastroenterology 169
- Cancer Research 461
- Surgery 977
Countries citing papers authored by Mercè Jordà
This map shows the geographic impact of Mercè Jordà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mercè Jordà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mercè Jordà more than expected).
Fields of papers citing papers by Mercè Jordà
This network shows the impact of papers produced by Mercè Jordà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mercè Jordà. The network helps show where Mercè Jordà may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mercè Jordà, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 13 | |
| 12 | 2018 | 10 | |
| 13 | 2017 | 49 | |
| 14 | 2012 | 41 | |
| 15 | 2009 | 58 | |
| 16 | 2009 | 21 | |
| 17 | EUS-guided fine needle aspiration with and without trucut biopsy of pancreatic masses. | 2008 | 26 |
| 18 | 2007 | 39 | |
| 19 | 2002 | 5 | |
| 20 | 2002 | 32 |
About Mercè Jordà
Mercè Jordà is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Surgery and Cancer Research, having authored 157 papers that have together received 3.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Prostate Cancer Treatment and Research (22 papers), Prostate Cancer Diagnosis and Treatment (21 papers), Bladder and Urothelial Cancer Treatments (20 papers), Urinary and Genital Oncology Studies (18 papers), Renal and related cancers (15 papers), Neuroendocrine Tumor Research Advances (12 papers) and Urologic and reproductive health conditions (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Oncology (1.0k citations), Gastroenterology (169 citations), Cancer Research (461 citations) and Surgery (977 citations). Mercè Jordà has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Parvin Ganjei‐Azar, Mehrdad Nadji, Andrew Hanly, Carmen Gomez‐Fernandez, Mark S. Soloway, Oleksandr N. Kryvenko, George W. Elgart, Murugesan Manoharan, Jonathan I. Epstein and Viacheslav Iremashvili. Their work appears in journals such as Archives of Pathology & Laboratory Medicine, The Journal of Urology, Cancer Cytopathology, Cancer and Applied immunohistochemistry & molecular morphology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.